{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:34:46Z","timestamp":1788863686751,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.vph.2024.107285","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T04:27:06Z","timestamp":1709267226000},"page":"107285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Angina pectoris 2023: With and without obstructive coronary artery disease: Epidemiology, diagnosis, prognosis, and treatment"],"prefix":"10.1016","volume":"155","author":[{"given":"Rasha K.","family":"Al-Lamee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2024.107285_bb0005","article-title":"Management of ischaemia with non-obstructive coronary arteries (INOCA)","volume":"375","author":"Beltrame","year":"2021","journal-title":"Bmj"},{"issue":"14","key":"10.1016\/j.vph.2024.107285_bb0010","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of ischemic heart disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.vph.2024.107285_bb0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jacc.2022.08.814","article-title":"Evolving management paradigm for stable ischemic heart disease patients: JACC review topic of the week","volume":"81","author":"Boden","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"17","key":"10.1016\/j.vph.2024.107285_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008868","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): what is the risk?","volume":"7","author":"Herscovici","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"16","key":"10.1016\/j.vph.2024.107285_bb0025","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker","year":"2022","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.vph.2024.107285_bb0030","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.vph.2024.107285_bb0035","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"10115","key":"10.1016\/j.vph.2024.107285_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2024.107285_bb0045","first-page":"61","article-title":"Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Health Serv. Insights"},{"issue":"10","key":"10.1016\/j.vph.2024.107285_bb0050","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jama.293.10.1223","article-title":"Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review","volume":"293","author":"Garg","year":"2005","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.vph.2024.107285_bb0055","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (type 2 diabetes evaluation of ranolazine in subjects with chronic stable angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl H","key":"10.1016\/j.vph.2024.107285_bb0060","doi-asserted-by":"crossref","first-page":"H32","DOI":"10.1093\/eurheartjsupp\/suac058","article-title":"Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR","volume":"24","author":"Ganesananthan","year":"2022","journal-title":"Eur. Heart J. Suppl."},{"issue":"2","key":"10.1016\/j.vph.2024.107285_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ehjdh\/ztac015","article-title":"Daily angina documentation versus subsequent recall: development of a symptom smartphone app","volume":"3","author":"Nowbar","year":"2022","journal-title":"Eur. Heart J. Digit Health"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T12:53:29Z","timestamp":1733403209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189124000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":13,"alternative-id":["S1537189124000107"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2024.107285","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angina pectoris 2023: With and without obstructive coronary artery disease: Epidemiology, diagnosis, prognosis, and treatment","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2024.107285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107285"}}